David A. Melnick SEC EDGAR Filings (CIK 0001726485)

SEC EDGAR filings, ownership reports, and insider transactions for David A. Melnick.

Business address
C/O Spero Therapeutics, Inc., 675 Massachusetts Ave., 14 Th Floor, Cambridge, MA, 02139
Top holdings (ownership)
SPRO
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
David A. Melnick has filed 7 SEC EDGAR filings since 05 Jan 2018

Latest Filings

Recent SEC filings for David A. Melnick including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Feb 2022 01 Feb 2022 001-38266
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 Aug 2021 26 Aug 2021 001-38266
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Feb 2021 01 Feb 2021 001-38266
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Feb 2020 03 Feb 2020 001-38266
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 02 Jan 2019 02 Jan 2019 001-38266
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 05 Jan 2018 04 Jan 2018 001-38266
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 05 Jan 2018 04 Jan 2018 001-38266

About this filer

David A. Melnick files with the SEC under CIK 0001726485. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages